PNC Financial Services Group
EVFM

PNC Financial Services Group’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

PNC Financial Services Group’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-66
Closed – – 4738
2022
Q2 		$0 Sell
66
-1
-1% -$2 ﹤0.01% 4867
2022
Q1 		$0 Hold
67
– – ﹤0.01% 4802
2021
Q4 		$0 Hold
67
– – ﹤0.01% 4711
2021
Q3 		$1K Hold
67
– – ﹤0.01% 4249
2021
Q2 		$1K Buy
+67
New +$1.27K ﹤0.01% 4167
2020
Q4 		– Sell
-2
Closed – – 4132
2020
Q3 		$0 Hold
2
– – ﹤0.01% 4119
2020
Q2 		$0 Buy
+2
New +$135 ﹤0.01% 4113
2015
Q3 		– Sell
-22
Closed -$18K – 4737
2015
Q2 		$18K Buy
+22
New +$14.1K ﹤0.01% 3557

Other funds holding EVFM

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

PNC Financial Services Group's EVFM Position: Q3 2022 in Review

PNC Financial Services Group sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2022, closing a stake of 66 shares.

PNC Financial Services Group first reported a position in EVFM in Q2 2015 and held it in 8 quarters. The position peaked at $18K in Q2 2015. 8 funds tracked by Wall St. Rank hold EVFM as of Q3 2022.

  • PNC Financial Services Group reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • PNC Financial Services Group sold 66 Evofem Biosciences, Inc. Common Stock shares in Q3 2022.
  • PNC Financial Services Group first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2015 and held it in 8 quarters.
  • PNC Financial Services Group's Evofem Biosciences, Inc. Common Stock position peaked at $18K in Q2 2015.
  • 8 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2022.

Based on PNC Financial Services Group's 13F filing for Q3 2022, filed 10 Nov 2022.